[ad_1]
Zevra Therapeutics ZVRA reported its This fall earnings outcomes on Thursday, March 28, 2024 at 04:32 PM.
This is what buyers have to know concerning the announcement.
Earnings
Zevra Therapeutics missed estimated earnings by -48.0%, reporting an EPS of $-0.4 versus an estimate of $-0.27.
Income was up $10.92 million from the identical interval final yr.
Previous Earnings Efficiency
Final quarter the corporate missed on EPS by $0.1 which was adopted by a 1.0% enhance within the share worth the subsequent day.
This is a have a look at Zevra Therapeutics’s previous efficiency:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | This fall 2022 |
---|---|---|---|---|
EPS Estimate | -0.3 | -0.39 | -0.23 | -0.17 |
EPS Precise | -0.4 | -0.15 | -0.34 | -0.26 |
Income Estimate | 3.38M | 2.90M | 2.65M | 3.20M |
Income Precise | 2.90M | 8.47M | 2.88M | 2.30M |
To trace all earnings releases for Zevra Therapeutics visit their earnings calendar here.
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
Benzinga simplifies the marketplace for smarter investing
Commerce confidently with insights and alerts from analyst scores, free stories and breaking information that impacts the shares you care about.
[ad_2]
Source link